Literature DB >> 23486293

Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect.

Cenk Ayata1, Hwa Kyoung Shin, Ergin Dileköz, Dmitriy N Atochin, Satoshi Kashiwagi, Katharina Eikermann-Haerter, Paul L Huang.   

Abstract

Hyperlipidemia is a highly prevalent risk factor for coronary and cervical atherosclerosis and stroke. However, even in the absence of overt atherosclerosis, hyperlipidemia disrupts endothelial and smooth muscle function. We investigated the impact of hyperlipidemia on resting-brain perfusion, fundamental cerebrovascular reflexes, and dynamic perfusion defect during acute focal ischemia in hyperlipidemic apolipoprotein E knockout mice before the development of flow-limiting atherosclerotic stenoses. Despite elevated blood pressures, absolute resting cerebral blood flow was reduced by 20% in apolipoprotein E knockout compared with wild type when measured by [(14)C]-iodoamphetamine technique. Noninvasive, high spatiotemporal resolution laser speckle flow imaging revealed that the lower autoregulatory limit was elevated in apolipoprotein E knockout mice (60 vs. 40 mm Hg), and cortical hyperemic responses to hypercapnia and functional activation were attenuated by 30% and 64%, respectively. Distal middle cerebral artery occlusion caused significantly larger perfusion defects and infarct volumes in apolipoprotein E knockout compared with wild type. Cerebrovascular dysfunction showed a direct relationship to the duration of high-fat diet. These data suggest that hyperlipidemia disrupts cerebral blood flow regulation and diminishes collateral perfusion in acute stroke in the absence of hemodynamically significant atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23486293      PMCID: PMC3677117          DOI: 10.1038/jcbfm.2013.38

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  38 in total

Review 1.  Is cholesterol a risk factor for stroke?: Yes.

Authors:  A M Demchuk; D C Hess; L M Brass; F M Yatsu
Journal:  Arch Neurol       Date:  1999-12

2.  Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations.

Authors:  Katharina Eikermann-Haerter; Jeong Hyun Lee; Izumi Yuzawa; Christina H Liu; Zhipeng Zhou; Hwa Kyoung Shin; Yi Zheng; Tao Qin; Tobias Kurth; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

3.  The behavioural effect of middle cerebral artery occlusion on apolipoprotein-E deficient mice.

Authors:  J P Hatcher; D Virley; S J Hadingham; J Roberts; A J Hunter; A A Parsons
Journal:  Behav Brain Res       Date:  2002-04-01       Impact factor: 3.332

Review 4.  Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction.

Authors:  P Amarenco
Journal:  Neurology       Date:  2001       Impact factor: 9.910

5.  Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein e-deficient mice.

Authors:  L V d'Uscio; L A Smith; Z S Katusic
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

6.  Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice.

Authors:  L V d'Uscio; T A Baker; C B Mantilla; L Smith; D Weiler; G C Sieck; Z S Katusic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-06       Impact factor: 8.311

7.  Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice.

Authors:  Kazuo Yamashiro; Alexandra B Milsom; Johan Duchene; Catherine Panayiotou; Takao Urabe; Nobutaka Hattori; Amrita Ahluwalia
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

8.  Cerebral CO2 reactivity, cholesterol, and high-density lipoprotein cholesterol in the elderly.

Authors:  S L Bakker; F E de Leeuw; P J Koudstaal; A Hofman; M M Breteler
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

9.  Effect of cerebrovascular risk factors on regional cerebral blood flow.

Authors:  Peter Jan van Laar; Yolanda van der Graaf; Willem P T M Mali; Jeroen van der Grond; Jeroen Hendrikse
Journal:  Radiology       Date:  2007-11-21       Impact factor: 11.105

10.  CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.

Authors:  Eunhee Kim; Aaron T Tolhurst; Lu Ye Qin; Xin-Yuan Chen; Maria Febbraio; Sunghee Cho
Journal:  J Neurosci       Date:  2008-04-30       Impact factor: 6.167

View more
  25 in total

1.  Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke.

Authors:  Hwa Kyoung Shin; Fumiaki Oka; Ji Hyun Kim; Dmitriy Atochin; Paul L Huang; Cenk Ayata
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Requisite ischemia for spreading depolarization occurrence after subarachnoid hemorrhage in rodents.

Authors:  Fumiaki Oka; Ulrike Hoffmann; Jeong Hyun Lee; Hwa Kyoung Shin; David Y Chung; Izumi Yuzawa; Shih-Pin Chen; Yahya B Atalay; Ala Nozari; Kristen Park Hopson; Tao Qin; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 3.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 4.  Microvascular Dysfunction and Cognitive Impairment.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

5.  Probucol inhibits LPS-induced microglia activation and ameliorates brain ischemic injury in normal and hyperlipidemic mice.

Authors:  Yeon Suk Jung; Jung Hwa Park; Hyunha Kim; So Young Kim; Ji Young Hwang; Ki Whan Hong; Sun Sik Bae; Byung Tae Choi; Sae-Won Lee; Hwa Kyoung Shin
Journal:  Acta Pharmacol Sin       Date:  2016-06-27       Impact factor: 6.150

6.  Rho-kinase inhibition improves ischemic perfusion deficit in hyperlipidemic mice.

Authors:  Hwa Kyoung Shin; Paul L Huang; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

7.  Targeting Myeloid-Specific Integrin α9β1 Improves Short- and Long-Term Stroke Outcomes in Murine Models With Preexisting Comorbidities by Limiting Thrombosis and Inflammation.

Authors:  Nirav Dhanesha; Manish Jain; Amit K Tripathi; Prakash Doddapattar; Mehul Chorawala; Girish Bathla; Manasa K Nayak; Madankumar Ghatge; Steven R Lentz; Shigeyuki Kon; Anil K Chauhan
Journal:  Circ Res       Date:  2020-03-20       Impact factor: 17.367

8.  Genetic Restoration of Plasma ApoE Improves Cognition and Partially Restores Synaptic Defects in ApoE-Deficient Mice.

Authors:  Courtney Lane-Donovan; Wen Mai Wong; Murat S Durakoglugil; Catherine R Wasser; Shan Jiang; Xunde Xian; Joachim Herz
Journal:  J Neurosci       Date:  2016-09-28       Impact factor: 6.167

Review 9.  Blood-brain barrier dysfunction and recovery after ischemic stroke.

Authors:  Xiaoyan Jiang; Anuska V Andjelkovic; Ling Zhu; Tuo Yang; Michael V L Bennett; Jun Chen; Richard F Keep; Yejie Shi
Journal:  Prog Neurobiol       Date:  2017-10-05       Impact factor: 11.685

Review 10.  Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective.

Authors:  Eduardo Candelario-Jalil; Surojit Paul
Journal:  Exp Neurol       Date:  2020-10-07       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.